# Agilysys Inc: overview

AGYS · Nasdaq · CIK 78749 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/agys.md) · [Financials](/companies/agys/financials.md) · [Filings](/companies/agys/filings.md) · [Insiders](/companies/agys/insiders.md)

Latest reported revenue: [$87.7m](/filings/0001193125-26-318081.md) for Q1 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 27, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-318081).

## Last eight quarters

| Line item | Unit | Q2 FY2024 (2024-09-30) | Q3 FY2024 (2024-12-31) | Q4 FY2024 (2025-03-31) | Q1 FY2025 (2025-06-30) | Q2 FY2025 (2025-09-30) | Q3 FY2025 (2025-12-31) | Q4 FY2025 (2026-03-31) | Q1 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [68.3](/filings/0001193125-25-251592.md) | [69.6](/filings/0001193125-26-022793.md) | [74.3 d](/filings/0001193125-26-234423.md) | [76.7](/filings/0001193125-26-318081.md) | [79.3](/filings/0001193125-25-251592.md) | [80.4](/filings/0001193125-26-022793.md) | [82.9 d](/filings/0001193125-26-234423.md) | [87.7](/filings/0001193125-26-318081.md) |
| Gross margin | % | [63.3%](/filings/0001193125-25-251592.md) | [63.0%](/filings/0001193125-26-022793.md) | [60.7% d](/filings/0001193125-26-234423.md) | [61.7%](/filings/0001193125-26-318081.md) | [61.7%](/filings/0001193125-25-251592.md) | [62.5%](/filings/0001193125-26-022793.md) | [64.4% d](/filings/0001193125-26-234423.md) | [63.5%](/filings/0001193125-26-318081.md) |
| Operating margin | % | [6.0%](/filings/0001193125-25-251592.md) | [10.7%](/filings/0001193125-26-022793.md) | [7.1% d](/filings/0001193125-26-234423.md) | [5.9%](/filings/0001193125-26-318081.md) | [17.8%](/filings/0001193125-25-251592.md) | [14.6%](/filings/0001193125-26-022793.md) | [15.2% d](/filings/0001193125-26-234423.md) | [11.1%](/filings/0001193125-26-318081.md) |
| Net margin | % | [2.0%](/filings/0001193125-25-251592.md) | [5.5%](/filings/0001193125-26-022793.md) | [5.3% d](/filings/0001193125-26-234423.md) | [6.4%](/filings/0001193125-26-318081.md) | [14.8%](/filings/0001193125-25-251592.md) | [12.3%](/filings/0001193125-26-022793.md) | [14.8% d](/filings/0001193125-26-234423.md) | [10.3%](/filings/0001193125-26-318081.md) |
| Diluted EPS | $ per share | [0.05](/filings/0001193125-25-251592.md) | [0.14](/filings/0001193125-26-022793.md) | not reported | [0.17](/filings/0001193125-26-318081.md) | [0.41](/filings/0001193125-25-251592.md) | [0.35](/filings/0001193125-26-022793.md) | not reported | [0.32](/filings/0001193125-26-318081.md) |
| Free cash flow | $m | [5.9 d](/filings/0001193125-25-251592.md) | [19.7 d](/filings/0001193125-26-022793.md) | [26.5 d](/filings/0001193125-26-234423.md) | [(5.0)](/filings/0001193125-26-318081.md) | [15.0 d](/filings/0001193125-25-251592.md) | [22.7 d](/filings/0001193125-26-022793.md) | [35.4 d](/filings/0001193125-26-234423.md) | [7.3](/filings/0001193125-26-318081.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-03-31) | FY2022 (2023-03-31) | FY2023 (2024-03-31) | FY2024 (2025-03-31) | FY2025 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [163](/filings/0000950170-24-063222.md) | [198](/filings/0000950170-25-076527.md) | [237](/filings/0001193125-26-234423.md) | [276](/filings/0001193125-26-234423.md) | [319](/filings/0001193125-26-234423.md) |
| Gross margin | % | [62.4%](/filings/0000950170-24-063222.md) | [61.0%](/filings/0000950170-25-076527.md) | [60.7%](/filings/0001193125-26-234423.md) | [62.4%](/filings/0001193125-26-234423.md) | [62.6%](/filings/0001193125-26-234423.md) |
| Operating margin | % | [3.9%](/filings/0000950170-24-063222.md) | [6.5%](/filings/0000950170-25-076527.md) | [6.6%](/filings/0001193125-26-234423.md) | [8.2%](/filings/0001193125-26-234423.md) | [13.5%](/filings/0001193125-26-234423.md) |
| Net margin | % | [4.0%](/filings/0000950170-24-063222.md) | [7.4%](/filings/0000950170-25-076527.md) | [36.3%](/filings/0001193125-26-234423.md) | [8.4%](/filings/0001193125-26-234423.md) | [12.1%](/filings/0001193125-26-234423.md) |
| Diluted EPS | $ per share | [0.18](/filings/0000950170-24-063222.md) | [0.49](/filings/0000950170-25-076527.md) | [3.17](/filings/0001193125-26-234423.md) | [0.82](/filings/0001193125-26-234423.md) | [1.37](/filings/0001193125-26-234423.md) |
| Free cash flow | $m | [27.3](/filings/0000950170-24-063222.md) | [27.2](/filings/0000950170-25-076527.md) | [40.1](/filings/0001193125-26-234423.md) | [52.3](/filings/0001193125-26-234423.md) | [68.1](/filings/0001193125-26-234423.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/agys/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $431.7m | 4,131,139 |  | Added +236,359 |
| [MAK CAPITAL ONE LLC](/funds/1385702.md) | 2026-06-30 | $124.6m | 1,192,730 |  | Unchanged |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $119.4m | 1,142,492 |  | Added +4,482 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $116.7m | 1,117,088 |  | Added +40,049 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $114.2m | 1,093,162 |  | Added +52,188 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $98.0m | 937,420 |  | Reduced −16,310 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $91.7m | 877,928 |  | Added +144,148 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $77.8m | 744,802 |  | Reduced −91,633 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $73.7m | 705,109 |  | Added +45,803 |
| [Artisan Partners Limited Partnership](/funds/1466153.md) | 2026-06-30 | $72.4m | 692,735 |  | Added +153,412 |

## Recent filings

[All 1,352 filings](/companies/agys/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 16:05 ET | [8-K](/filings/0001193125-26-431911.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-431911 |
| 2026-09-04 | 16:05 ET | [8-K](/filings/0001193125-26-383628.md) | 5.07 Shareholder vote results | 0001193125-26-383628 |
| 2026-07-27 | 16:11 ET | [10-Q](/filings/0001193125-26-318081.md) | Quarterly report, period 2026-06-30 | 0001193125-26-318081 |
| 2026-07-27 | 16:05 ET | [8-K](/filings/0001193125-26-318055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-318055 |
| 2026-07-16 | 16:11 ET | [DEF 14A](/filings/0001193125-26-306113.md) | Proxy statement, period 2026-07-16 | 0001193125-26-306113 |
| 2026-06-22 | 08:30 ET | [8-K](/filings/0001193125-26-276749.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-276749 |
| 2026-06-03 | 08:30 ET | [8-K](/filings/0001193125-26-254661.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-254661 |
| 2026-05-21 | 16:11 ET | [10-K](/filings/0001193125-26-234423.md) | Annual report, period 2026-03-31 | 0001193125-26-234423 |
| 2026-05-18 | 16:05 ET | [8-K](/filings/0001193125-26-228898.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-228898 |
| 2026-02-02 | 08:30 ET | [8-K](/filings/0001193125-26-032780.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-032780 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001193125-26-234423.md), filed May 21, 2026.

## Forecast league

Q2 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/eee2b357-5d6b-4c08-bd7c-5077ab527914)

## About the filer

- CIK: 78749
- Tickers: AGYS
- Exchange: Nasdaq
- SIC code: 7373 Services-Computer Integrated Systems Design
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:12 ET. No prices; not investment advice.